Metal working – Method of mechanical manufacture – Assembling or joining
Reexamination Certificate
2001-05-23
2003-07-22
Bryant, David P. (Department: 3726)
Metal working
Method of mechanical manufacture
Assembling or joining
C128S898000, C604S506000
Reexamination Certificate
active
06594880
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
In general, this invention relates to infusion catheters. More specifically, this invention relates to an intraparenchymal infusion catheter system for delivering a therapeutic agent into an organism where the catheter has a porous tip which has a perfusion surface area that may be matched to the target volume.
2. Description of the Related Art
When chronic administration of a pharmaceutically active agent is required, internal delivery by an external infusion pump or an implantable infusion pump (“IIP”), in combination with a catheter, may be the desired delivery means. For example, IIP-catheter delivery may be preferred when, for example, the site specific delivery of the drug is critical, or the drug must be administered in tightly controlled, yet minute dosages.
In current catheter designs, the delivered agent ordinarily flows out of the catheter via a fixed number of elution holes. Most catheter designs utilize either a single elution hole or a few elution holes. The current designs suffer from at least two notable disadvantages. To begin with, the fixed number of elution holes may make it difficult to tailor the catheter to the drug flow rates dictated for a particular drug and a particular parenchymal target. In many neurological applications, the quantity of delivered drug is relatively minute and must be carefully tailored. Some flexibility in flow rate is achieved by calibrating the IIP, although it is still desirable to be able to more carefully tailor the number of elution holes to the desired flow rate. In addition, current catheter designs present a fixed external perfusion surface area to a selected parenchymal target volume. Since the perfusion area is fixed, it may be difficult to match the perfusion area to the parenchymal target volume. For example, if the parenchymal target volume consists of a five centimeter long malignant mass, and the perfusion area of the catheter is only three centimeters in length, it may be very difficult to achieve infusion of a cytostatic agent through the entire length of the mass. Furthermore, there may be applications where it is desirable to minimize the volume displacement of the catheter tip into the selected parenchymal target in order to minimize tissue trauma. If the perfusion area of the catheter tip is fixed, no such tailoring is possible.
The present invention is directed at solving one or more of the above-noted problems.
SUMMARY OF THE INVENTION
A catheter system for delivering fluid to a selected site within an organism comprises a pump for delivering the fluid and a catheter coupled to the pump. The catheter comprises a first tubular portion that has a generally cylindrical lumen of a first internal diameter and is composed of a relatively impermeable material. A second tubular portion that has an open end is disposed within the lumen and a closed distal end is disposed without the lumen. The second tubular portion is composed of a flexible, porous material having a preselected microporosity that is operable to permit fluid to flow from the catheter into the organism. The second tubular portion is selectively moveable with respect to the first tubular portion.
Alternatively, a catheter for delivering fluid to a selected site within an organism comprises a first tubular portion that has a generally cylindrical lumen of a first internal diameter and is composed of a relatively impermeable material. A second tubular portion that has an open end is disposed within the lumen and a closed distal end is disposed without the lumen. The second tubular portion is composed of a flexible, porous material that has a preselected microporosity that is operable to permit fluid to flow from the catheter into the organism. The second tubular portion is selectively moveable with respect to the first tubular portion.
REFERENCES:
patent: 1852351 (1932-04-01), Lewis
patent: 3123072 (1964-03-01), Bellamy, Jr.
patent: 3470604 (1969-10-01), Zenick
patent: 3640269 (1972-02-01), Delgado
patent: 3894541 (1975-07-01), El-Shafei
patent: 3941119 (1976-03-01), Corrales
patent: 4186745 (1980-02-01), Lewis et al.
patent: 4300244 (1981-11-01), Bokros
patent: 4613324 (1986-09-01), Ghajar
patent: 4670313 (1987-06-01), Saudagar
patent: 4686085 (1987-08-01), Osterholm
patent: 4710181 (1987-12-01), Fuqua
patent: 4717387 (1988-01-01), Inoue et al.
patent: 4767400 (1988-08-01), Millern et al.
patent: 4781672 (1988-11-01), Hooven
patent: 4806182 (1989-02-01), Rydell et al.
patent: 4875468 (1989-10-01), Krauter et al.
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 4943560 (1990-07-01), Wigness et al.
patent: 4968306 (1990-11-01), Huss et al.
patent: 4976703 (1990-12-01), Franetzki et al.
patent: 4983169 (1991-01-01), Furukawa
patent: 4990155 (1991-02-01), Wilkoff
patent: 4994047 (1991-02-01), Walker et al.
patent: 4998938 (1991-03-01), Ghajar et al.
patent: 5011472 (1991-04-01), Aebischer et al.
patent: 5106627 (1992-04-01), Aebischer et al.
patent: 5169387 (1992-12-01), Kronner
patent: 5171305 (1992-12-01), Schickling et al.
patent: 5180387 (1993-01-01), Ghajar et al.
patent: 5192753 (1993-03-01), McGeer et al.
patent: 5199427 (1993-04-01), Strickland
patent: 5203776 (1993-04-01), Durfee
patent: 5218957 (1993-06-01), Strickland
patent: 5244619 (1993-09-01), Burnham
patent: 5255675 (1993-10-01), Kolobow
patent: 5282785 (1994-02-01), Shapland et al.
patent: 5385541 (1995-01-01), Kirsch et al.
patent: 5399346 (1995-03-01), Anderson et al.
patent: 5405316 (1995-04-01), Magram
patent: 5460618 (1995-10-01), Harreld
patent: 5468221 (1995-11-01), Schö{umlaut over ( )}ner
patent: 5478807 (1995-12-01), Cronin et al.
patent: 5542935 (1996-08-01), Unger et al.
patent: 5552415 (1996-09-01), May
patent: 5643207 (1997-07-01), Rise
patent: 5683357 (1997-11-01), Magram
patent: 5728061 (1998-03-01), Ahmed
patent: 5756553 (1998-05-01), Iguchi et al.
patent: 5772261 (1998-06-01), Magram
patent: 5846220 (1998-12-01), Elsberry
patent: 5880116 (1999-03-01), Vigo-Pelfrey
patent: 5895378 (1999-04-01), Berenstein et al.
patent: 6056725 (2000-05-01), Elsberry
patent: 6093180 (2000-07-01), Elsberry
patent: 6140116 (2000-10-01), Dinsmore
patent: WO 94/15663 (1994-07-01), None
patent: WO 94/26341 (1994-11-01), None
Dorland's Illustrated Medical Dictionary, W.B. Saunders Company, Twenty-Sixth Edition, p. 189.
Breitner, J.C.S. et al., “Inverse Association of Anti-Inflammatory Traetments and Alzheimer's Disease: Initial Results of a Co-Twin Control Study”,Neurology, vol. 44, pp. 227-232 (Feb., 1994).
Duong, Taihung et al., “Microtubule-association Proteins Tau and Amyloid P Component in Alzheimer's Disease”,Brain Reaserch, vol. 608, pp. 74-86 (1993).
Eikelenboom, Piet et al., “Inflammatory Mechanisms in Alzheimer's Disease”,TiPs, vol. 15, pp. 447-450 (Dec. 1994).
Forloni, Gianluigi et al., “Expression of Amyloid Precursor Portein mRNAs in Endothelial, Neuronal and Glial Cells: Modulation by Interleukin-1”,Molecular Brain Reasearch, vol. 19, pp. 128-133 (1992).
Malmberg, A.B. et al., “Hyperalgesia Mediated by Spinal Glutamate or Substance P Receptor Blocked by Spinal Cycloxygenase Inhibition”,Science, vol. 257, pp. 1276-1279 (Aug. 28, 1992).
Meade, E.A. et al., “Differential Inhibition of Prostaglandin Endoperoxide Synthase (Cyclooxygenase) Isozymes by Aspirin and Other Non-steroidal Anti-inflammatory Drugs”, Journal of Biological Chemistry, vol. 268, No. 9, pp. 6610-6614 (Mar. 25, 1993).
Mitchell, J.A. et al., “Selectivity of Nonsteroidal Antiinflammatory Drugs as Inhibitors of Constitutive and Inducible Cyclooxygenase”,Proceedings of the National Academy of Sciences, vol. 90, No. 24, pp. 1693-1697 (Dec. 15, 1993).
Murphy, M., “The Molecular Pathogenesis of Alzheimer's Disease: Clinical Prospects”, vol. 340, pp. 1512-1515 (Dec. 19/26, 1992).
Netland, E.E. et al., “Indomethacin Reverse &bgr;-amyloid Induced Gliosis”, Department of Psychiatry and Human Behavior, Miriam Hospital and Brown University Medical School, 11 pgs. (Date Unknown).
Netland, E., “Neuropathological and Cognitive Impairment in a
Bauer Stephen W.
Bryant David P.
Cozart Jermie E.
Medtronic Inc.
LandOfFree
Intraparenchymal infusion catheter system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intraparenchymal infusion catheter system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intraparenchymal infusion catheter system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3103288